TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $149,026 | -66.4% | 17,826 | -0.1% | 0.00% | -100.0% |
Q2 2023 | $443,319 | +88.0% | 17,847 | +13.8% | 0.00% | 0.0% |
Q1 2023 | $235,767 | +16.4% | 15,676 | -8.5% | 0.00% | 0.0% |
Q4 2022 | $202,636 | +132.9% | 17,129 | +16.6% | 0.00% | – |
Q3 2022 | $87,000 | +35.9% | 14,686 | -1.9% | 0.00% | – |
Q2 2022 | $64,000 | -72.3% | 14,963 | -38.4% | 0.00% | – |
Q1 2022 | $231,000 | -57.0% | 24,295 | -14.1% | 0.00% | -100.0% |
Q4 2021 | $537,000 | -1.8% | 28,297 | +72.2% | 0.00% | -50.0% |
Q3 2021 | $547,000 | -57.6% | 16,428 | -50.6% | 0.00% | -50.0% |
Q2 2021 | $1,290,000 | -17.8% | 33,256 | +2.2% | 0.00% | -20.0% |
Q1 2021 | $1,569,000 | +18.1% | 32,545 | +27.4% | 0.01% | 0.0% |
Q4 2020 | $1,328,000 | +264.8% | 25,538 | +87.6% | 0.01% | +150.0% |
Q3 2020 | $364,000 | +42.2% | 13,613 | +3.7% | 0.00% | +100.0% |
Q2 2020 | $256,000 | +96.9% | 13,128 | +12.4% | 0.00% | 0.0% |
Q4 2019 | $130,000 | +21.5% | 11,682 | +2.1% | 0.00% | 0.0% |
Q2 2014 | $107,000 | -1.8% | 11,442 | -27.3% | 0.00% | 0.0% |
Q1 2014 | $109,000 | – | 15,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |